Worldwide Sodium Channel Seminars
Edition 2021-2022 - Next Seminar on Dec. 14, 2021.

Prof. Angelika Lampert (RWTH Aachen University, Germany) and Prof. Hugues Abriel (University of Bern, Switzerland) are currently the two co-organizers of the Worldwide Sodium Channel Seminars. Dr. Jannis Körner (RWTH Aachen University, Germany) and Dr. Oksana Iamshanova (University of Bern, Switzerland) are the junior co-organizers of this series of seminars.

 

Angelika Lampert, MD, is a full professor at the Institute of Physiology (Neurophysiology) at the RWTH Aachen University, Germany. She is the coordinator of the Sodium Channel Network Aachen (SCN Aachen) focusing on inherited neuropathic pain syndromes such as small fiber neuropathy linked to sodium channel mutations. Her research focuses on the translation of laboratory findings to potential clinical treatment, either as a population therapy or personalized medicine, with two main focuses:  1) biophysics and structure-function relation of voltage-gated sodium channels and their disease-linked mutations, and 2) induced pluripotent stem cells (iPS-cells) and their differentiation into peripheral sensory neurons as a model for human neuropathies in the dish.

Follow her on Twitter here.

Hugues Abriel, MD PhD, is a full professor of molecular medicine at the Institute of Biochemistry and Molecular Medicine of the University of Bern, Switzerland. He is the director of the Swiss National Science Foundation-funded research network NCCR TransCure. His research work focuses on the roles of ion channels in human diseases (channelopathies). Currently, he is mainly exploring the genetic, molecular, and cellular basis of cardiac arrhythmias. To this aim, his group is involved in the characterization of mutations found in patients with inherited arrhythmic syndromes such as the Brugada syndrome and congenital Long QT syndrome. Another focus of the group is to investigate the roles of regulatory proteins interacting with cardiac ion channels such as Nav1.5 and TRPM4.

Follow him on Twitter here.